Academic literature on the topic 'Head and Neck tumor'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Head and Neck tumor.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Head and Neck tumor"

1

Harahap, Sondang Nora, and Daan Khambri. "Small Cell Neuroendocrine Carcinoma in Head and Neck." Indonesian Journal of Cancer 15, no. 4 (December 28, 2021): 211. http://dx.doi.org/10.33371/ijoc.v15i4.805.

Full text
Abstract:
Introduction: Poorly differentiated neuroendocrine carcinomas (NECs) originating from the eye are rare and very highly malignant diseases with a poor prognosis. Small cell NEC of the head and neck is a rare disease and highly aggressive. Early recognition and treatment are crucial for reducing morbidity and mortality. Case Presentation: A 19-year-old male visited our oncology surgery outpatient department due to the progressive neck mass enlargement originating from the eye. The patient was previously diagnosed with invasive choroid malignant melanoma of the left eye which had metastasized to the lymph nodes of the left neck. He underwent a surgical removal/exenteration of the left eye. The result showed that the patient’s survival with poorly differentiated tumors was about 14% while patients with well-differentiated NEC had a survival rate of 34%. It also indicates that the prognosis of these tumors is very poor with a total of over 90% of patients having distant metastatic disease. Histopathological examination showed the tumor tissue and its immunohistochemistry with positive streaks of CD56, NSE, Synaptophysin, and Ki67 suggested small cell NEC.Conclusions: it is crucial to establish an early diagnosis of these tumors to reduce morbidity and mortality. No optimal treatment for such disease has yet been established.
APA, Harvard, Vancouver, ISO, and other styles
2

Barnes, Precious, F. A. Yeboah, Jinling Zhu, Roland Osei Saahene, Christian Obirikorang, Michael Buenor Adinortey, Benjamin Amoani, Foster Kyei, Patrick Akakpo, and Yaw Asante Awuku. "Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors." Journal of Cancer Epidemiology 2020 (November 12, 2020): 1–7. http://dx.doi.org/10.1155/2020/5615303.

Full text
Abstract:
Introduction. Head and neck tumors (HNT) are tumors that normally occur at the head and neck region of the body. Epidermal growth factor receptor (EGFR) has been found to be highly expressed in breast and other tumors; therefore, there is the need to investigate the level of EGFR expression among patients with head and neck tumors in Ghana. Method. The level of EGFR expression was determined in head and neck tumor and control head and neck tissues with quantitative real-time PCR and immunohistochemistry analysis. Results. The level of EGFR expressions was high in tumor tissues than in the control tissues. There was a significant difference of p value 0.025 among the ages >40 and ≤ 40 when the high and low level of EGFR was compared in the head and neck malignant tumor. The area under the curve for the high expression of EGFR among the malignant head and neck tumors was 0.901 with a specificity of 86.4%. Conclusion. EGFR can serve as a prognostic marker in monitoring patients with HNT as well as a molecular therapeutic target.
APA, Harvard, Vancouver, ISO, and other styles
3

Zahrani, Faisal Al, Khalid Al-Qahtani, Mohammed Alshahrani, Khamis Almufargi, Abdullah Alkhudhayri, Labeb Obad, and Tahera Islam. "Incidence of Lymphatic Metastasis to Neck Nodes Level IIb in Neck Dissection for Head and Neck Cancers: A Retrospective Study." International Journal of Head and Neck Surgery 5, no. 3 (2014): 99–103. http://dx.doi.org/10.5005/jp-journals-10001-1192.

Full text
Abstract:
ABSTRACT Introduction Selective neck dissection (SND) is performed to prevent head and neck cancers metastasis. We tried to determine the incidence of level IIb lymph nodes metastasis and it is associations in head and neck cancers for selection of patients requiring SND. Materials and methods A retrospective study was conducted on 57 patients who underwent surgical removal of the head and neck tumor by 84 neck dissections. Fisher exact test was used to measure the association between positive IIb nodes and the other variables. Results Nine (15.8%) of 57 patients showed level IIb lymph nodes metastasis comprising 10.71% of the 84 neck dissections. Six (66.66%) were associated with oral cavity cancers, 8 (88.9%) with squamous cell carcinoma (SCC), 6 (66.66%) with T4 tumor. Five (55.6%) were N2b, and 7 (77.8%) were found in N+ necks. All (100%) positive IIb nodes were associated with metastatic level IIa. Significant associations were found betweenpositive IIbnodesand N2b (p= 0.005), clinically N+ necks (p = 0.005) and IIa (p < 0.01). Conclusion The incidence of level IIb nodes metastasis is high so they should be removed in any oral tumor, SCC, advanced staging, N+ necks or positive IIa lymph nodes metastasis. How to cite this article Al zahrani F, Al-Qahtani K, Alshahrani m, Almufargi K, Alkhudhayri A, Obad l, Islam T. Incidence of lymphatic metastasis to Neck Nodes level IIb in Neck Dissection for Head and Neck Cancers: A Retrospective Study. Int J Head Neck Surg 2014;5(3):99-103.
APA, Harvard, Vancouver, ISO, and other styles
4

Wangaryattawanich, Pattana, Mohit Agarwal, and Tanya Rath. "Imaging features of cartilaginous tumors of the head and neck." Journal of Clinical Imaging Science 11 (December 4, 2021): 66. http://dx.doi.org/10.25259/jcis_186_2021.

Full text
Abstract:
There is a wide spectrum of head and neck cartilaginous lesions which include both neoplastic and nonneoplastic processes. Cartilaginous tumors of the head and neck are uncommon, posing a diagnostic challenge. Benign cartilaginous tumors that may occur in the head and neck include chondroma, chondroblastoma, chondromyxoid fibroma, osteochondroma, and synovial chondromatosis. Chondromesenchymal hamartoma is a rare non-neoplastic cartilaginous lesion that is included for the 1first time in the new WHO classification and radiologically can mimic a tumor. Malignant cartilaginous tumors include chondrosarcoma and chondroid variant of chordoma. Characteristic tumor locations, internal chondroid matrix calcification, and typical T2 hyperintense signal secondary to high-water content within the extracellular matrix of the hyaline cartilage are useful imaging features that narrow the differential diagnosis and help in diagnosing these diseases. This article presents a narrative review of the anatomy of the head and neck cartilaginous structures, discusses the current knowledge and imaging spectrum of benign and malignant cartilaginous tumors and tumor-like lesions of the head and neck.
APA, Harvard, Vancouver, ISO, and other styles
5

Masuda, Muneyuki, Fumihide Rikimaru, Satoshi Toh, and Yuichiro Higaki. "Transmanubrial Approach for Removing a Head and Neck Tumor Located at the Upper Lateral Mediastinum." Biomedicine Hub 2, no. 3 (December 9, 2017): 1–6. http://dx.doi.org/10.1159/000484685.

Full text
Abstract:
Background: When a head and neck tumor invades the upper lateral mediastinum, the transmanubrial approach (TMA), in which the sternoclavicular joint is temporary mobilized and replaced back to the physiological position, appears to be an excellent method. However, there have been only a few reports about the application of this approach to head and neck tumors. Materials and Methods: We recently adopted this technique for the removal of 2 head and neck tumors that required handling of the subclavian and innominate veins around the venus angle. Results: We could safely remove the tumors under good surgical view and obtained excellent cosmetic and functional results. Conclusions: TMA is a useful technique for the removal of head and neck tumors, which invade the upper lateral mediastinum. More frequent applications of this method are encouraged in combination with head and neck tumor surgery.
APA, Harvard, Vancouver, ISO, and other styles
6

Hanazawa, Toyoyuki. "Biopsy of Head and Neck Tumor." Practica Oto-Rhino-Laryngologica 104, no. 1 (2011): 82–83. http://dx.doi.org/10.5631/jibirin.104.82.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

MIKAMI, YASUKAZU, MAMORU TSUKUDA, IZUMI MOCHIMATSU, TOSHIYUKI KOKATSU, TADAYUKI YAGO, SHUJI SAWAKI, and TAKAAKI ITO. "ANGIOGENESIS IN HEAD AND NECK TUMOR." Nippon Jibiinkoka Gakkai Kaiho 96, no. 4 (1993): 645–50. http://dx.doi.org/10.3950/jibiinkoka.96.645.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Jumaniyazova, Enar, Anastasiya Lokhonina, Dzhuliia Dzhalilova, Anna Kosyreva, and Timur Fatkhudinov. "Immune Cells in Head-and-Neck Tumor Microenvironments." Journal of Personalized Medicine 12, no. 9 (September 16, 2022): 1521. http://dx.doi.org/10.3390/jpm12091521.

Full text
Abstract:
Head-and-neck cancers constitute a heterogeneous group of aggressive tumors with high incidence and low survival rates, collectively being the sixth most prevalent cancer type globally. About 90% of head-and-neck cancers are classified as squamous cell carcinomas (HNSCC). The innate and adaptive immune systems, indispensable for anti-cancer immune surveillance, largely define the rates of HNSCC emergence and progression. HNSCC microenvironments harbor multiple cell types that infiltrate the tumors and interact both with tumor cells and among themselves. Gradually, tumor cells learn to manipulate the immune system, either by adapting their own immunogenicity or through the release of immunosuppressive molecules. These interactions continuously evolve and shape the tumor microenvironment, both structurally and functionally, facilitating angiogenesis, proliferation and metastasis. Our understanding of this evolution is directly related to success in the development of advanced therapies. This review focuses on the key mechanisms that rule HNSCC infiltration, featuring particular immune cell types and their roles in the pathogenesis. A close focus on the tumor-immunity interactions will help identify new immunotherapeutic targets in patients with HNSCC.
APA, Harvard, Vancouver, ISO, and other styles
9

Nemec, Stefan Franz, Andreas M. Herneth, and Christian Czerny. "Perineural Tumor Spread in Malignant Head and Neck Tumors." Topics in Magnetic Resonance Imaging 18, no. 6 (December 2007): 467–71. http://dx.doi.org/10.1097/rmr.0b013e3181645a0d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ahlawat, Parveen, Sheh Rawat, Anjali Kakria, Manoj Pal, Deepika Chauhan, Ruparna Khurana, and Sarthak Tandon. "Utilization and incorporation of tumor volume data in staging and prognostication of head and neck squamous cell carcinoma treated with definitive radiotherapy: A systematic review." Asian Journal of Oncology 01, no. 01 (January 2015): 021–32. http://dx.doi.org/10.4103/2454-6798.165089.

Full text
Abstract:
AbstractHead and neck squamous cell cancers (HNSCC) are a group of heterogeneous tumors, evident by their diverse behavior and natural history. The largest diameter of tumor measured for T classification may not necessarily reflect the true tumor dimension. There is a need to take into account certain other feature(s) of these tumors other than the maximum single dimension which can reflect the true tumor burden more accurately. Tumor volume has been shown to be a useful and accurate tool burden because it is a measurement of tumor burden in all three dimensions. This review article has compiled and reviewed the literature published in past on impact of tumor volumes (TVs) on the prognosis of head and neck cancers. A comprehensive literature search was performed in PubMed for terms “clonogens,” “TV” or “primary TV (PTV)” or “nodal volume” or “total TV (TTV)” or “volumetric analysis of TV in head and neck” or “predicting response in head and neck cancer” “prognostic factors head and neck cancers” and “outcome in head and neck cancer.” We identified 33 studies which have commented on the impact of TV in HNSCC on treatment outcome, 9 of these had analyzed PTV, 11 studies had analyzed total nodal volume, and 14 studies have analyzed TTV. Besides these, we have dealt with laryngeal cancers separately with 9 studies. This review article is also aimed to enhance our knowledge further regarding how best a physician can incorporate TV data in staging and predicting response to radiotherapy.
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Head and Neck tumor"

1

Andrews, Nigel Anthony. "Intrinsic cellular radiosensitivity in head and neck cancer." Thesis, University of Liverpool, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367189.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Viblom, Jonathan, and Jonas Emauelsson. "Mandibular Reconstruction after Head and Neck Tumor Treatment, a Systematic Review." Thesis, Umeå universitet, Institutionen för odontologi, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-97844.

Full text
Abstract:
Objectives This systematic literature review examined the literature about mandibular reconstruction after cancer treatment with segmental resection, with focus on  success rate for the reconstruction, patient survival rate, dental rehabilitation and how this effect the patients QOL, oral function and aesthetics.   Material and methods A search was performed in Pubmed, a database of scientific articles, based on four keywords (Mandibular, Reconstruction, Cancer, Segmental). After screening using our inclusion and exclusion criteria’s, 89 articles were chosen. A data base in excel was established to sort the information we needed for our study.     Results Sixty out of the 89 included articles were in full text and 29 were abstracts. The median year of publication was 2006 (range 1977 to 2013). A total of 5629 patients were included in the literature review. Of these, 3783 patients were included in articles that had categorized by gender and we found that 65.4% were males and 34.6% were females. The total success rate for reconstruction therapies including plate, vascularized- and non-vascularized bone transplant was 86.4% in 3219 patients (range from 70.4% in the plate group to 92.3% in the non-vascular group). The mean follow up time were 46.9 mounts (range 0.2 – 216 months).   Conclusion This literature review indicates a focus on success rates for different kinds of reconstruction techniques. The overall success rate for non- and vascularized bone reconstruction techniques were very high compared to plate reconstruction only. To evaluate patient-related factors such as function, aesthetics and quality of life, further prospective randomized studies is required.
APA, Harvard, Vancouver, ISO, and other styles
3

Chan, Chiu-lung Richie, and 陳肖龍. "Mucosal melanoma of the head and neck." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2011. http://hub.hku.hk/bib/B46632876.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sundelin, Kaarina. "Head and Neck Cancer : Factors Affecting Tumour Growth." Doctoral thesis, Linköping : Univ, 2007. http://www.bibl.liu.se/liupubl/disp/disp2007/med1032s.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Boldrup, Linda. "p63 and potential p63 targets in squamous cell carcinoma of the head and neck." Doctoral thesis, Umeå : Univ, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1522.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nordemar, Sushma. "Methods for early diagnosis of head and neck cancer /." Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-872-6/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lara, Ana. "FDG tumor volumetric parameters and outcome in lung cancer and head and neck cancer." Thesis, Boston University, 2012. https://hdl.handle.net/2144/12464.

Full text
Abstract:
Thesis (M.A.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Authorization To Manage form for this thesis or dissertation. It is therefore not openly accessible, though it may be available by request. If you are the author or principal advisor of this work and would like to request open access for it, please contact us at open-help@bu.edu. Thank you.
Lung cancer (LC) is the leading cause of cancer mortality worldwide and second most common type of cancer in the United States in both genders. Moreover, Head and neck cancer (HNC) is the sixth most common cancer worldwide and 4% of all malignancies in the United States. The role of FDG-PET-CT has recently increased in oncology for diagnosis, treatment monitoring and patient prognosis. FDG Metabolic parameters sued to assess patient care include maximum standard uptake value (SUVmax), metabolic tumor volume (MTV), and total glycolytic activity. This study attempts to prove FDG-metabolic parameters reliability in LC and HNC patients before and after treatment among readers with different levels of experience. Three readers, 2 experienced and 1 inexperienced, read before and after treatment scans of 74 FDG-PET-CT scans from 13 lung cancer patients and 24 head and neck cancer patients. Lesion location was provided beforehand and reliability was tested using intra-class correlation coefficients (ICC) and ANOVA analysis. For every case, ICC was >0.81 (almost perfect agreement) among all readers and ANOVA showed no statistical significance (p>0.05) on the any of the measurements among all readers as well. We concluded that FDG-PET-CT metabolic parameters (SUVmax, MTV, and TGA) are reliable measurements for treatment response in LC and HNC patients and are independent of reader experience as long as lesion location is provided. These parameters have been found to accurately correlate with tumor behavior and patient prognosis; therefore, reliability on its accurate measurement provides strength to FDG-PET-CT as an imaging modality of choice for oncology patients.
APA, Harvard, Vancouver, ISO, and other styles
8

Murray, Patrick Francis. "Immunomodulation within the head and neck tumour microenvironment." Thesis, University of Hull, 2014. http://hydra.hull.ac.uk/resources/hull:10124.

Full text
Abstract:
Changes in the immune response have been implicated in the progression of squamous cell carcinoma of the head and neck (HNSCC). Evidence is emerging that processes within the tumour microenvironment can lead to immune modulation and subsequent tumour growth or metastasis. The hypothesis of this thesis is that the HNSCC tumour microenvironment will have increased levels of cytokines that produce an overall negative effect on the cellular cytotoxic immune response against the malignant cells. Specifically, it is hypothesised that a Th-2-like anti-inflammatory response will favour tumour cell progression and be associated with advanced stage HNSCC. This thesis examines the levels of a panel of immune cytokines to investigate whether difference in these levels have an association with the progression of the disease and other standard clinico-pathological factors. A method of protein extraction from tumour tissue and detection of quantitative cytokine levels was developed and optimised. A cohort of 69 patients newly-presenting with HNSCC was recruited prospectively to the study, with a total of 83 samples of primary HNSCC tumour tissue and metastatic nodal tissue being investigated. Increased levels of TGF-β, described as concentration of cytokine/mg total protein extracted, (median 1051 pg/mg vs. 659 pg/mg, p= 0.004) and reduced levels of IL-17 (median 4.2pg/mg vs. median 18.6 pg/mg, p= 0.009), compared with normal tissue from control patients were reported. The HNSCC samples were also found to have higher levels of VEGF in tumour samples (83 pg/mg vs. 27.6 pg/mg, p=0.026) compared with control tissue. No difference was found in the levels of IL-2, IL-10, IL-12, IL-15, or IL-17. When comparing early stage (I-III) to late stage IV HNSCC patients it was found that there were significantly lower levels of the Th1-like IL-12 in the higher stage IV patients (median 50pg/mg vs. 21 pg/mg, p= 0.01), and significantly higher levels of IL-15 in stage IV patients (median 52 pg/mg, vs. 20 pg/mg p= 0.03). In summary, analysis of cytokine levels within the tumour microenvironment of HNSCC may be of prognostic value, and further study of the immune suppressive nature of HNSCC could open potential therapeutic approaches, especially if such data are correlated with other cellular parameters, e.g. T regulatory or CD8+ve T cell levels.
APA, Harvard, Vancouver, ISO, and other styles
9

Haylock, Anna-Karin. "Targeting molecules for diagnostics of Head and Neck squamous cell carcinoma." Doctoral thesis, Uppsala universitet, Öron-, näs- och halssjukdomar, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-315210.

Full text
Abstract:
To personalize treatment for cancer, correct staging of the primary tumor, nodal disease and metastatic disease is of essence. By targeting tumor specific receptors with radiolabeled antibodies, specificity and accuracy of imaging may be improved. Radio-immunodiagnostics can potentially detect small volume disease, occult metastasis and recurrent cancer in treated tissue. This thesis focuses on evaluation of radio-immunoconjugates directed towards CD44v6, which is a surface receptor overexpressed in many head and neck squamous cell carcinomas. At the outset, the monoclonal chimeric antibody cMab U36 and its cleavage products Fab’ and F(ab’)2 were labeled with 125I and assessed in vitro and in vivo (paper I). The best distribution pattern and tumor to organ ratio was achieved with F(ab’)2. Due to the immunological responses humans can develop towards chimeric antibodies, they are not optimal for clinical use, and subsequently fully human antibody fragments were developed. AbD15179, which is a monovalent fragment, was labeled with 111In and 125I and evaluated in vitro and in mice bearing CD44v6-expressing tumors. Tumor to organ ratios were improved compared to cMab U36 derived fragments, and 111In-AbD15179 displayed a more favorable distribution compared to 125I-AbD15179 (Paper II). A bivalent Fab-dHXL, AbD19384 derived from AbD15179, was then constructed and labeled with 125I and evaluated in cell- and biodistribution studies. Furthermore, an imaging study in a small animal PET was performed with 124I-AbD19384 (Paper III). Uptake in kidneys was reduced and liver uptake increased compared to AbD15179 reflecting the larger molecule. The high CD44v6 expressing tumor was clearly visualized with maximum uptake at 48 hours post injection.In paper IV human single chain fragments towards CD44v6v were selected, and the top candidates A11 and H12 were further evaluated in vitro and in vivo. Single chain fragments are small molecules exhibiting fast clearance and high affinity to the target. The study proved this by demonstrating superior tumor to blood ratios of radiolabeled A11 and H12 compared to previously studied molecules.
APA, Harvard, Vancouver, ISO, and other styles
10

Bradburn, Jennifer Elizabeth. "Reactive species promotion of head and neck squamous cell carcinoma." Columbus, Ohio : Ohio State University, 2007. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1166555968.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Head and Neck tumor"

1

Andrearczyk, Vincent, Valentin Oreiller, and Adrien Depeursinge, eds. Head and Neck Tumor Segmentation. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-67194-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Andrearczyk, Vincent, Valentin Oreiller, Mathieu Hatt, and Adrien Depeursinge, eds. Head and Neck Tumor Segmentation and Outcome Prediction. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-98253-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rahbar, Reza, Carlos Rodriguez-Galindo, John G. Meara, Edward R. Smith, and Antonio R. Perez-Atayde, eds. Pediatric Head and Neck Tumors. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-8755-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Vicky S. M. Head and neck. 2nd ed. New York: Igaku-Shoin, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Qizilbash, Ali H. Head and neck. New York: Igaku-Shoin, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Head and neck pathology. 2nd ed. Philadelphia, PA: Elsevier Saunders, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

I, Chiosea Simion, and Seethala Raja R, eds. Head and neck pathology. New York: Demos Medical Pub., 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nayak, Umanath, Ravikanti Satya Prasad, and Shobana Sekhar. Clinical Radiology of Head and Neck Tumors. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-5036-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

J, Gullane Patrick, and Johnson Jonas T, eds. A practical approach to head and neck tumors. New York: Raven Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

W, Gilbert Ralph, and Stell, P. M. (Philip Michael), eds. Stell & Maran's textbook of head and neck surgery and oncology. 5th ed. London: Hodder Arnold, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Head and Neck tumor"

1

Kovács, Adorján F. "Head and Neck." In Locoregional Tumor Therapy, 125–38. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-36572-0_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kovács, Adorján F. "Head and Neck." In Locoregional Tumor Therapy, 199–211. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-69947-9_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sarioglu, Sulen. "Tumor Deposits in Head and Neck Tumors." In Tumor Deposits, 151–70. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-68582-3_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mack, Martin G., and Thomas J. Vogl. "Head and Neck Lesions." In Percutaneous Tumor Ablation in Medical Radiology, 215–19. Boston, MA: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-36891-7_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Padwa, Bonnie L. "Giant Cell Tumor." In Pediatric Head and Neck Tumors, 165–70. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8755-5_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mack, Jennifer W. "Carcinoma/Undifferentiated Tumor." In Pediatric Head and Neck Tumors, 81–86. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-8755-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Schantz, Stimson P., Howard E. Savage, and Norris K. Lee. "Head and Neck Tumor Immunology." In Cancer Treatment and Research, 243–63. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4613-1499-8_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Deek, Andrew, and Eric R. Carlson. "Head and Neck Tumor Surgery." In The History of Maxillofacial Surgery, 251–79. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-89563-1_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gartrell, Brian C., and Samuel P. Gubbels. "Glomus Tumor." In Encyclopedia of Otolaryngology, Head and Neck Surgery, 1029. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-23499-6_200060.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ma, Jun, and Xiaoping Yang. "Combining CNN and Hybrid Active Contours for Head and Neck Tumor Segmentation in CT and PET Images." In Head and Neck Tumor Segmentation, 59–64. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-67194-5_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Head and Neck tumor"

1

Nagle, Luz, Amy Mackay Weber, MacLean Hall, Matthew Beatty, J. Trad Wadsworth, Caitlin McMullen, Krupal Patel, Kathryn Vorwald, Christine Chung, and Shari Pilon-Thomas. "Abstract 2178: Expansion of tumor-specific tumor-infiltrating lymphocytes (TIL) from head and neck tumors." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-2178.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kumar, Dhruv, Partha Kasturi, Bennett Van Houten, and Sufi Thomas. "Abstract 1139: Tumor-associated fibroblasts facilitate head and neck cancer metabolism." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1139.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yang, Kyung-Min, WonJoo Kim, Jeong-Mi Lee, and Seong-Jin Kim. "Abstract 4411: DRAK1 overexpressed in head and neck cancer suppresses the TGF-β1 tumor suppressor activity in head and neck cancer cells." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-4411.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jansen, F., N. Möckelmann, and A. Böttcher. "The pleomorphic liposarcoma - a rare tumor manifestation in the head and neck." In 100 JAHRE DGHNO-KHC: WO KOMMEN WIR HER? WO STEHEN WIR? WO GEHEN WIR HIN? Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1727944.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Duong Dinh, TA, E. Mici, A. Otremba, J. Ilgner, and M. Westhofen. "Neuroendocrine tumors of the head and neck." In Abstract- und Posterband – 90. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Digitalisierung in der HNO-Heilkunde. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1685982.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Irlanda, Pacheco-Bravo, Hidalgo-Tobon Silvia, Zaragoza Kena, Reynoso-Noverón Nancy, De Celis-Alonso Benito, and Delgado-Hernandez Rosa. "ADC biomarker for head and neck tumors." In XIII MEXICAN SYMPOSIUM ON MEDICAL PHYSICS. AIP Publishing LLC, 2014. http://dx.doi.org/10.1063/1.4901384.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vakoulovskaya, Elena G., Victor V. Shental, N. A. Abdoullin, Yury P. Kuvshinov, T. D. Tabolinovskaia, N. J. Edinak, Boris K. Poddubny, et al. "Photodynamic therapy of head and neck tumors." In BiOS Europe '96, edited by Stanley B. Brown, Benjamin Ehrenberg, and Johan Moan. SPIE, 1996. http://dx.doi.org/10.1117/12.260763.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Makarava, N. I., and M. N. Piatkevich. "TREATMENT PLANNING PROTOCOLS FOR HEAD AND NECK TUMORS IRRADIATION." In SAKHAROV READINGS 2021: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2021. http://dx.doi.org/10.46646/sakh-2021-2-66-69.

Full text
Abstract:
In order to provide high-quality radiation therapy at the National Cancer Center of Belarus, a group of medical physicists developed the first local protocol in Belarus for radiotherapy treatment planning of head and neck tumors patients. The protocol contains grounded practice-oriented recommendations based on the long-term clinical experience of qualified medical physicists in treating patients with head and neck tumors for irradiation using modern linear accelerators.
APA, Harvard, Vancouver, ISO, and other styles
9

Hess, J., S. Homann, N. Koerich Laureano, B. Tawk, M. Bieg, X. Pastor Hostenech, K. Freier, W. Weichert, K. Zaoui, and J. Hess. "Tumor cell plasticity in the pathogenesis and prognosis of head and neck cancer." In Abstract- und Posterband – 89. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn – Forschung heute – Zukunft morgen. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1640039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kumar, Dhruv, Vikalp Vishwakarma, Jacob New, Radhika Joshi, Fangchen Lin, Sumana Dasari, Wade Gutierrez, et al. "Abstract 1030: Targeting tumor-stroma metabolic symbiosis for head and neck cancer therapy." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1030.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Head and Neck tumor"

1

Pereira, Daniela, Diana Martins, and Fernando Mendes. Immunotherapy in Head and Neck Cancer When, How and Why? INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

LaFiandra, Michael E., and Harry Zywiol. Mounted Combat System Crew Shock Loading: Head and Neck Injury Potential Evaluation. Fort Belvoir, VA: Defense Technical Information Center, July 2007. http://dx.doi.org/10.21236/ada469753.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Poindexter, Samuel E. Comparing Immunohistologic and Demographic Variables of Head and Neck Squamous Cell Carcinoma. Fort Belvoir, VA: Defense Technical Information Center, May 2015. http://dx.doi.org/10.21236/ad1012738.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Halldin, Peter, Sofia Hedenstierna, Karin Brolin, and Hans von Holst. Finite Element Analysis of the Effects of Head-Supported Mass on Neck Responses. Fort Belvoir, VA: Defense Technical Information Center, September 2006. http://dx.doi.org/10.21236/ada456789.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shender, Barry, Glenn Paskoff, Greg Askew, Rich Coughlan, and Wayne Isdahl. Head and Neck Loads and Moments Developed During Tactical and Rotary Wing +Gz-Stress. Fort Belvoir, VA: Defense Technical Information Center, January 2000. http://dx.doi.org/10.21236/ada389301.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shender, Barry S., Glenn Paskoff, Gregory Askew, Richard Coughlan, and Wayne Isdahl. Determination of Head and Neck Loads and Moments During Tactical and Rotary Wing Maneuvering Acceleration. Fort Belvoir, VA: Defense Technical Information Center, September 2001. http://dx.doi.org/10.21236/ada390466.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zhang, Dongyuan, Zhengze Wang, Jingwen Li, Chengliang Ren, and Shen Tian. Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: An updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2020. http://dx.doi.org/10.37766/inplasy2020.9.0074.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wade, Amber L., Judy L. Dye, Charlene R. Mohrle, and Michael R. Galarneau. Head, Face, and Neck Injuries During Operation Iraqi Freedom II: Results From the US Navy and Marine Corps Combat Trauma Registry. Fort Belvoir, VA: Defense Technical Information Center, January 2006. http://dx.doi.org/10.21236/ada445195.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Amoroso, Paul J., Nicole S. Bell, Holly Toboni, and Mark Krautheim. A Baseline Historical Analysis of Neck and Back-Related Morbidity in the U.S. Army: Occupational Risks Potentially Related to Head-Supported Mass. Fort Belvoir, VA: Defense Technical Information Center, September 2005. http://dx.doi.org/10.21236/ada440190.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zhan, Ze-Jiang, Fang Zhang, Wen-Ze Qiu, Tai-Ze Yuan, and Rong-Hui Zheng. The optimal second-line treatment model for recurrent and/or metastatic head and neck squamous cell carcinoma: a Bayesian network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2020. http://dx.doi.org/10.37766/inplasy2020.11.0041.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography